IQVIA (NYSE: IQV) Expands Early-Stage Drug Discovery Capabilities with Acquisition of Charles River Discovery Assets IQVIA Holdings Inc. (NYSE: IQV) announced an agreement to acquire select discovery services assets from Charles River Laboratories, strengthening its early-stage R&D capabilities. The assets include five sites offering in vitro drug discovery, AI-driven small molecule platforms, and advanced non-animal research methods backed by over 20 years of scientific data. These capabilities will enhance IQVIA’s integrated platform across drug discovery, from target identification to early safety assessment, covering key therapeutic areas like oncology, neurology, and immunology. The move positions IQVIA to support clients earlier in the drug development lifecycle. The transaction is expected to close in Q2 2026. (Link)
GSK (NYSE: GSK) Agrees to Acquire 35Pharma for $950 Million to Bolster Cardiopulmonary Pipeline GSK announced an agreement to acquire 35Pharma Inc., a Canada-based clinical-stage biopharma company focused on novel protein-based therapeutics. The deal gives GSK full ownership of 35Pharma and its lead asset HS235, a potential best-in-class activin receptor signaling inhibitor targeting pulmonary arterial hypertension (PAH) and pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF). The acquisition strengthens GSK’s Respiratory, Immunology and Inflammation portfolio, addressing unmet needs in a high-burden disease with a growing market projected to reach $18 billion by 2032. GSK will pay $950 million in cash for 100% equity, subject to regulatory approvals, with closing expected thereafter. (Link)
Exa Capital Expands Healthcare Software Portfolio with Acquisition of StaffReady, a Leader in Clinical Workforce Management SaaS Exa Capital, a long-term investor specializing in enterprise software, has acquired StaffReady, a SaaS platform for clinical workforce management in healthcare. Founded in 1995, StaffReady provides cloud-native tools for staff scheduling, compliance, and inspection readiness across hospital departments and life sciences organizations. The deal strengthens Exa Capital’s healthcare technology portfolio and marks its entry into clinical workforce optimization, a sector critical to operational efficiency and patient safety. StaffReady will continue to operate independently under Exa’s decentralized model, with its leadership team remaining in place to drive innovation and sustainable growth backed by Exa’s strategic support. (Link)
Numantec Expands Infusion Therapy Portfolio with Acquisition of DualCap® Product Line from Merit Medical financed by Banco BPM and Muzinich & Co Numantec, a global infusion therapy device manufacturer, has acquired the DualCap® product line from Merit Medical Systems through its U.S. subsidiary, Health Line International Corp. The DualCap® is an established antimicrobial cap used in vascular access and infusion therapy, enhancing infection prevention and clinical efficiency. The acquisition strengthens Numantec’s vascular access portfolio and creates growth opportunities across Europe and the U.S., where DualCap® already has a strong customer base. Health Line, which has manufactured DualCap® since before 2017, will ensure continuity of supply. The transaction was financed by Banco BPM and Muzinich & Co. (Link)
Healthcare Triangle (Nasd: HCTI) Announces $3.96 Million Registered Direct Offering Priced at-the-Market to Support Growth Initiatives Healthcare Triangle, Inc. (Nasdaq: HCTI), a digital transformation leader for healthcare and life sciences, announced it has entered into definitive agreements to sell 681,553 shares of common stock (or prefunded warrants) at $5.81 per share in a registered direct offering priced at-the-market under Nasdaq rules. The gross proceeds are expected to total approximately $3.96 million before fees and expenses. The offering, conducted under the company’s effective Form S-3 shelf registration, is expected to close around February 27, 2026, subject to customary conditions. (Link)
The HWP Group Acquires Global Market Access Solutions to Strengthen Market Access and Health Economics Expertise Backed by NMS Capital The HWP Group, a leading medical communications and strategic consulting firm for the life sciences sector, has acquired Global Market Access Solutions (GMAS), a global consultancy specializing in market access and health economics. The acquisition expands HWP’s capabilities in HEOR, pricing and payer insights, evidence synthesis, and lifecycle value strategy, enhancing support across the entire product lifecycle—from early development to sustained patient access. CEO Jani Hegarty said the deal reinforces HWP’s mission to bridge science and real-world access. Backed by NMS Capital, the move positions HWP as a fully integrated partner for pharmaceutical and biotechnology innovators. (Link)
QC Capital Invests in My Pediatric Doctor to Expand Nationwide 24/7 Urgent Pediatric Telehealth Platform QC Capital Group, a Charlotte-based alternative investment firm, announced a strategic investment in My Pediatric Doctor, a nationwide 24/7 pediatric telehealth platform offering on-demand access to board-certified providers. Led by CEO Eric Doherty, the company aims to modernize pediatric care by reducing emergency room visits and improving accessibility for families across all 50 states, Guam, and Puerto Rico. The platform integrates with healthcare systems to relieve pressure on hospitals while maintaining high clinical standards. QC Capital CEO Chris Salerno called the partnership a key step in delivering trusted, affordable pediatric care nationwide. (Link)
HCAP Partners Leads Follow-On Acquisition to Expand Integrated Diagnostic Services Platform with Core Analytics Lab & Radiology other partners include California Bank & Trust, along with co-investment from St. Cloud Capital and Southfield Mezzanine San Diego-based private equity and impact investor HCAP Partners has completed a follow-on acquisition for its Integrated Diagnostic Services (IDS) platform with the addition of Santa Fe Springs-based Core Analytics Lab & Radiology. The deal expands IDS’s footprint into Northern California and adds mobile laboratory diagnostics to its service offerings. Financing was provided by HCAP Partners, California Bank & Trust, along with co-investment from St. Cloud Capital and Southfield Mezzanine. Post-acquisition, IDS will serve over 440 facilities, offering bundled radiology and lab services to skilled nursing, long-term care, and home health providers across California. (Link)
Gemspring Capital Expands Spinal Device Platform as Portfolio Company Zavation Medical Acquires ChoiceSpine Zavation Medical Products, a Gemspring Capital portfolio company and manufacturer of spinal implants and biologics, has acquired ChoiceSpine Holdings, a Knoxville-based spinal implant designer. The transaction broadens Zavation’s product portfolio and national reach, leveraging its vertically integrated manufacturing to accelerate innovation. ChoiceSpine will keep its brand and operations during integration. Concurrently, Zavation appointed Derek Kuyper as CEO of the combined entity. Gemspring Capital said the acquisition strengthens Zavation’s market position and supports its strategy to build a scaled, innovation-driven spinal platform. (Link)
Fulcrum Equity Partners Leads $10M Growth Round in MedScout to Advance AI-Driven MedTech Sales Execution with participation from Live Oak Venture Partners and Stage 2 Capital Austin-based MedScout has raised $10 million in a growth funding round led by Fulcrum Equity Partners, with participation from Live Oak Venture Partners and Stage 2 Capital. The funding more than doubles MedScout’s valuation since its Series A in July 2024. The company also launched “Strategies,” a suite of AI agents designed to help MedTech commercial teams translate strategy into field-level execution. MedScout plans to use the capital to expand its AI capabilities amid surging enterprise demand. The company reported tripled enterprise revenue and rapid adoption growth as investors back its data-driven approach to commercial alignment in MedTech sales. (Link)
Chapters Health Expands West Coast Footprint with Housecall Providers Deal, Strengthening Nonprofit Hospice Network and Growth Potential Chapters Health System, the nation’s largest nonprofit hospice network, has signed a definitive agreement to acquire Housecall Providers from CareOregon, pending approval by the Oregon Health Authority. The move expands its Pacific Northwest presence and adds to its 2025 West Division growth, which includes affiliates in California, Nevada, and Oregon. The integration aligns two nonprofit leaders in community-based chronic and homecare, reinforcing Chapters’ national scale, operational synergies, and value-based care capabilities—key drivers for investors tracking nonprofit healthcare consolidation and sustainable care delivery models. (Link)
Dovida Enters U.S. Market with Acquisition of A Place At Home, Expanding Global Home Care Footprint to Seven Countries Global home care provider Dovida has entered the U.S. market through the acquisition of A Place At Home, a nationwide home care franchise network. The move marks Dovida’s seventh international market and first presence in North America, extending its person-centered care model across the United States. A Place At Home’s leadership will remain in place to ensure continuity for franchise owners and caregivers. The deal aligns with Dovida’s strategy to expand amid increasing demand for high-quality in-home care for older adults, reinforcing its mission to deliver personal, dignified, and relationship-based care on a global scale. (Link)
Ally Bridge Group Backs Creation of Precision IO Group as Quantum Surgical Acquires NeuWave Medical to Advance Robotic Cancer Care Quantum Surgical has acquired NeuWave Medical, Inc., combining expertise in robotic and microwave ablation technologies under a new parent entity, Precision IO Group Inc., led by medtech veteran Kurt Azarbarzin. Supported by investment from Ally Bridge Group, the group aims to expand access to minimally invasive, AI-driven, and remote cancer treatments worldwide. Both companies will continue operating independently, ensuring ongoing product availability. The Epione robotic platform and NeuWave’s microwave system will together drive broader adoption of next-generation interventional oncology procedures across global healthcare markets. (Link)
HIAAH Expands Mental Health Footprint with Strategic Acquisition of Broward Center for Counseling to Strengthen Market Presence in Broward County HIAAH, a U.S.-based integrated health care and mental health services provider, has acquired the Broward Center for Counseling as part of its expansion strategy in Broward County. The move reinforces HIAAH’s mission to broaden access to high-quality, compassionate mental health care while improving operational efficiency and client experience. The newly branded Broward Center for Counseling by HIAAH will continue providing individualized therapy for anxiety, depression, trauma, and relationship issues, now supported by enhanced infrastructure and a holistic, multidisciplinary care model. The acquisition aligns with HIAAH’s growth objectives and positions it for stronger long-term value creation in the behavioral health sector. (Link)
UConn Health Finalizes Waterbury Hospital Acquisition from Prospect Medical Holdings UConn Health is set to complete its acquisition of Waterbury Hospital from bankrupt for-profit Prospect Medical Holdings at midnight on Saturday, marking a major expansion of its health network. The facility will operate under a new entity, UConn Health Community Network, beginning Sunday at 12:01 a.m. Immediate changes include new signage, updated processes, and a ribbon-cutting ceremony on March 4. UConn Health plans to assess Waterbury’s healthcare needs, modernize information and safety systems, and introduce new specialists and services from its flagship John Dempsey Hospital in Farmington to strengthen local medical care and patient outcomes. (Link)
Bradford Health Expands into Midwest with Acquisition of Parkdale Center, Strengthening National Footprint in Specialized Professional Addiction Care Bradford Health Services, a nationally recognized addiction treatment provider, has acquired Parkdale Center, a leading Indiana-based facility specializing in confidential addiction recovery programs for healthcare providers, attorneys, executives, and other licensed professionals. The deal extends Bradford’s geographic reach into the Midwest and enhances its portfolio of evidence-based treatment offerings. Parkdale’s expertise in professional recovery, career reentry, and collaboration with licensing boards complements Bradford’s mission of clinical excellence and sustainable outcomes. Both organizations will maintain their brands while integrating operations to deliver expanded, high-quality care for professionals nationwide. Terms of the transaction were not disclosed. (Link)
Zemantics Ventures Strengthens Healthcare Portfolio with Acquisition of Consilium360 and MedWell360 Zemantics Ventures, a strategic investment and operating platform, has acquired Consilium360 and MedWell360 to expand its presence in healthcare services and workforce solutions. The move enhances Zemantics’ capabilities in enterprise HR optimization, patient access, and technology-enabled operational performance. Consilium360 provides data-driven workforce and HR strategy solutions for healthcare systems, while MedWell360 specializes in scheduling and access center services. The acquisitions support Zemantics’ strategy of scaling founder-led, service-driven businesses through strategic capital, shared infrastructure, and technology. John Brown, Founder and Healthcare HR Executive, will continue in a leadership role to ensure continuity and growth. (Link)
Epiphany Dermatology Expands Kansas Presence Through Partnership with Resolute Dermatology Epiphany Dermatology, a leading national dermatology network, has expanded its presence in Kansas by partnering with Resolute Dermatology, LLC, founded in 2020 by Dr. Daniel Christiansen. Based in Leawood and Shawnee, KS, Resolute Dermatology is recognized for high-quality patient care in the greater Kansas City area. The partnership brings Dr. Christiansen and his team—Drs. Julie Green, Elizabeth Spenceri, and PAs Judy Ky and Kylie Witham—into Epiphany’s growing network. Through this collaboration, Resolute gains operational and clinical support while sharing expertise across Epiphany’s 123 locations in 18 states, strengthening access to exceptional dermatologic care in the region. (Link)
Venture and Other News:
NewSpring Healthcare Leads $140 Million Investment in Honest Health to Accelerate Value-Based Care Expansion included participation from K2 HealthVentures and existing investors Rubicon Founders, Oak HC/FT, WCAS, and Durable Capital Partners Honest Health, a physician-led value-based care enablement firm, raised $140 million in a funding round led by NewSpring Healthcare, the healthcare-focused arm of NewSpring Capital. The round included participation from K2 HealthVentures and existing investors Rubicon Founders, Oak HC/FT, WCAS, and Durable Capital Partners. Proceeds will support national expansion and partnerships with health systems and payers. NewSpring will leverage its sector expertise to guide Honest Health’s growth in risk-based care models. (Link)
NantWorks Leads $240 Million Investment in SHINE Technologies; Dr. Patrick Soon-Shiong Joins Board to Advance Fusion and Cancer Therapies SHINE Technologies, a leader in fusion-based technology, has raised $240 million in new equity funding led by NantWorks, founded by Dr. Patrick Soon-Shiong, who also joins SHINE’s Board of Directors. Other investors include Fidelity, Sumitomo, Pelican Energy, Deerfield, and Oaktree. The funding supports SHINE’s commercial fusion initiatives in neutron testing, medical isotope production, and nuclear waste recycling, while accelerating Lu-177 radioisotope supply for precision cancer therapies. The strategic partnership gives NantWorks priority access to Lu-177, aligning SHINE’s fusion expertise with Soon-Shiong’s mission to transform oncology. With this round, SHINE’s total funding surpasses $1 billion. (Link)
BrainCheck Secures Additional $13 Million Series A to Scale AI-Enabled Cognitive Care Platform and Embedded Assessment Workflows Across Value-Based Health Systems BrainCheck, a digital platform for cognitive assessment and care, has raised an additional $13 million in Series A financing led by Next Coast Ventures, with S3 Ventures and UPMC Enterprises participating. The capital will expand its enterprise cognitive care infrastructure, including deeper EHR integration, longitudinal monitoring, AI-assisted population health analytics, and deployment across primary care and specialty settings. BrainCheck is partnering with collaborative care organizations to operationalize scalable cognitive care pathways in time-constrained, value-based environments. Used by 500+ providers, its FDA Class II BrainCheck Assess™ has powered over 640,000 assessments and 14,000 care plans to date. (Link)
YOU(th) Health Tech Raises $4.5M to Expand Smartphone-Based Preventive Health Screening Globally round led by Callisto Health, with support from caesar., adesso Ventures, Antler, Moonstone, and 1024 Ventures. Digital health startup YOU(th) has raised $4.5 million in a funding round led by Callisto Health, with support from caesar., adesso Ventures, Antler, Moonstone, and 1024 Ventures. Angel investors include Jean-Charles Samuelian (Alan, Mistral AI) and Patrick Andrae (HomeToGo). The company aims to democratize preventive healthcare by turning everyday smartphone data—such as facial videos, voice, typing patterns, and step counts—into quick health assessments detecting over 50 biomarkers across 10 organ systems. The funds will support product development and expansion of engineering, data science, and medical research teams to make preventive care accessible worldwide. (Link)
General Catalyst Leads $6.5M Seed in Baba to Build Continuous AI‑Enabled Patient Advocacy for Aging Americans General Catalyst has led a more than $6.5 million seed round in Baba, a patient advocacy startup founded by Connor Sweeney to help seniors and families navigate complex healthcare logistics. Inspired by his grandparents’ experience after his grandmother’s stroke, Sweeney built Baba to pair older adults with dedicated human advocates, augmented by AI tools for daily check-ins, medication management, and insurance and benefits navigation. With advocacy reimbursed by Medicare for over 70 million beneficiaries, Baba aims to scale continuous, preventive support through partnerships with home health, nursing homes, and post-acute care providers. (Link)
Coral Care Raises $13M Series A Led by Haymaker Ventures, Joined by FCA Ventures, Peterson Ventures, Alleycorp, Reach Capital, Jefferson River Capital, Greymatter Capital, Mother Ventures, and Charge Ventures to Expand In-Home Pediatric Therapy Nationwide Coral Care, a platform providing in-home pediatric speech, occupational, and physical therapy, has raised a $13 million Series A round led by Haymaker Ventures, with participation from FCA Ventures, Peterson Ventures, Alleycorp, Reach Capital, Jefferson River Capital, Greymatter Capital, Mother Ventures, and Charge Ventures. The funding will fuel national expansion in Dallas, Houston, Chicago, Philadelphia, and Pittsburgh, bringing operations to five states. Founded in 2023 by Jen Wirt, Coral Care supports over 400 licensed clinicians through its technology platform that streamlines administrative tasks and enables accessible, insurance-covered, in-home therapy for children across the U.S. (Link)
AI Healthtech Startup Lexi Raises $1.4M Pre-Seed Round Led by Informed Ventures, Backed by HBS Alumni Angels, Stanford Angels, Alumni Ventures, and Van Wickle Ventures Lexi, an AI-native communication platform for healthcare, has raised an oversubscribed $1.4 million pre-seed round led by Informed Ventures, with participation from HBS Alumni Angels, Stanford Angels, Alumni Ventures, and Van Wickle Ventures. Founded by Linh Pham and Siddharth UR, Lexi tackles language barriers affecting 30 million U.S. patients by providing secure, instant AI interpretation within clinical workflows. A successful pilot with Lowell Community Health Center delivered over 60,000 minutes of interpretation, reduced costs by 60%, and improved privacy and efficiency. Lexi plans to expand deployments across health centers while broadening language coverage and patient partnerships. (Link)
Eli Lilly (NYSE: LLY) acquires Orna Therapeutics for up to $2.4 billion to enter in vivo CAR-T therapy market The all-cash acquisition gives Lilly access to Orna’s engineered circular RNA platform combined with lipid nanoparticles to generate cell therapies within patients’ bodies. Orna’s lead asset, ORN-252, targets CD19 for B-cell-driven autoimmune diseases and is described as clinical trial-ready. Founded in 2021 with technology from MIT researchers Alex Wesselhoeft, Ph.D. and Professor Dan Anderson, Ph.D., Massachusetts-based Orna raised $321 million across seed and Series B rounds and established collaborations with Merck & Co. and Vertex. The platform aims to deliver more durable therapeutic protein expression than current RNA or cell therapy approaches, addressing complexity and cost challenges of ex vivo CAR-T therapies. (Link)
Sanofi (NASD: SNY) completes acquisition of Dynavax Technologies at $15.50 per share The acquisition includes Dynavax’s adult hepatitis B vaccine HEPLISAV-B, currently marketed in the U.S. with a differentiated two-dose regimen over one month, along with shingles vaccine candidate Z-1018 in phase 1/2 studies and additional vaccine pipeline projects. The tender offer expired on February 9, 2026, and Sanofi accepted all validly tendered shares on February 10, 2026. Following the merger under Delaware General Corporation Law Section 251(h), Dynavax became an indirect, wholly owned subsidiary of Sanofi. The transaction augments Sanofi’s adult immunization presence by combining Dynavax’s vaccines with Sanofi’s commercial reach, global scale, and development capabilities. (Link)
Waters Corporation (NYSE: WAT) completes combination with BD’s Biosciences & Diagnostic Solutions (NYSE: BDX) businesses through Reverse Morris Trust transaction, forming global life sciences and diagnostics leader The transaction creates a combined company with Waters shareholders holding 60.8% and BD shareholders owning 39.2% on a fully diluted basis. Waters has established four divisions: Waters Analytical Sciences (separations science and mass spectrometry), Waters Biosciences (flow cytometry and single cell multiomics), Waters Advanced Diagnostics (microbiology, molecular, and multiplex testing), and Waters Materials Sciences (thermal analysis and rheology). The company also appointed Dr. Claire M. Fraser, an internationally recognized genome scientist and former Director of The Institute for Genome Sciences at University of Maryland, to its Board of Directors, expanding the board to 11 members. (Link)
Harbor Health acquires Rippl with continued backing from Kin Ventures, ARCH Venture Partners, General Catalyst, GV, F-Prime Capital, JSL Health and Mass General Brigham Ventures to expand dementia support services The acquisition expands Harbor Health’s condition-focused care pathways into dementia management and extends its geographic footprint into Florida, building on its 2025 purchase of 32 VillageMD clinics. Rippl’s dementia care platform helps seniors remain at home while avoiding unnecessary emergency department visits, hospitalizations, and post-acute care through early identification of medical and behavioral issues. The program will be available at Harbor Health and VillageMD locations in Austin, Dallas, San Antonio, and El Paso for Medicare Advantage members and traditional Medicare beneficiaries through CMS’ GUIDE program, supporting Harbor Health’s proactive, integrated care-and-coverage model. (Link)
Patient Square Capital signs definitive agreement to acquire Paradigm from OMERS Private Equity The transaction reflects Patient Square’s long-standing relationship with Paradigm’s leadership and confidence in the company’s ability to manage complex, high-acuity cases while delivering measurable cost savings and improved outcomes. Walnut Creek-based Paradigm is a specialty care management organization focused on individuals with complex injuries and diagnoses, with growing leadership in payment integrity, home health, and network services across workers’ compensation and healthcare payer sectors. The acquisition marks the successful conclusion of Paradigm’s partnership with OMERS Private Equity. Patient Square will support Paradigm’s expansion beyond its proven workers’ compensation model into the broader healthcare landscape under CEO John S. Watts, Jr.’s leadership. (Link)
ReviveHealth acquires Doseform, via its financial sponsor Eir Partners, to integrate AI driven automation and patient engagement platform across pharmacy operations The acquisition establishes Doseform as the patient management system for Revive’s Pharmacy Centers of Excellence, with deployment planned across all pharmacy locations. Founded in 2021, Doseform uses AI-driven two-way messaging to streamline prescription workflows, payments, and patient communications through automated SMS and mobile links. The platform enables patients to view prescriptions, confirm orders, complete intake forms, and submit payments directly from phones without portals or apps. It addresses routine questions about refills, copays, and order status through AI-enabled chat, reducing inbound call volume and allowing pharmacy teams to focus on higher-value services while supporting rapid growth and operational efficiency. (Link)
Traumasoft acquires Huly, via its financial sponsor Serent Capital, to advance AI strategy for EMS industry Huly will retain its independent brand, leadership team, and R&D operations under Founder and CEO Nidhish Dhru, remaining accessible to EMS agencies regardless of their technology stack. The AI-native platform automates time-intensive administrative processes across pre-billing, Quality Assurance/Quality Improvement, and payroll workflows. Agencies using Huly report first-time billing rejections dropping from approximately 60% to near 10%, along with improved cash flow, accuracy, and staff productivity. Traumasoft customers will benefit from tightly integrated workflows connecting HMS, billing, QA/QI, and AI-driven automation. The structure allows Huly to innovate across the EMS ecosystem while delivering value within Traumasoft’s platform. (Link)
Humana Health’s (NYSE: HUM) CenterWell completes acquisition of MaxHealth from Arsenal Capital Partners to expand senior-focused primary care network The Florida-based primary care organization operates 54 owned primary care clinics, 4 owned specialty/ancillary clinics, and 24 downstream affiliate clinics throughout West and South Florida, serving more than 120,000 patients including over 80,000 in value-based care programs. MaxHealth will now be affiliated with CenterWell Senior Primary Care, the nation’s largest senior-focused, value-based primary care provider, expanding CenterWell’s reach into new key markets. MaxHealth will continue operating under CEO Michelle Leslie’s leadership. (Link)
Abound Health acquires Pro Care Unlimited, via its financial sponsors Housatonic Partners, Peterson Partners, The Cambria Group, Trilogy Search Partners, WSC & Company, Relay Investments, Aspect Investors and Endurance Search Partners, to expand intellectual and developmental disability services into Michigan Effective January 1, 2026, Michigan-based Pro Care Unlimited joined Abound Health while retaining its current name and leadership. Pro Care will gain access to Abound’s infrastructure, clinical oversight, leadership development programs, direct care worker recognition initiatives, emergency assistance through Abound Cares, and scholarships and training resources. Founded over 20 years ago in North Carolina, Abound Health now serves more than 6,000 individuals across North Carolina, Pennsylvania, New Jersey, and Michigan with over 7,500 team members. The acquisition aims to build one of Michigan’s most robust IDD networks. (Link)
Natus Sensory acquires TheraB Medical to expand neonatal phototherapy portfolio with FDA-cleared wearable technology The acquisition adds TheraB Medical’s SnugLit™, the first FDA-cleared wearable phototherapy system designed as a single swaddle-style garment for treating neonatal jaundice, to Natus Sensory’s newborn care portfolio. SnugLit received FDA 510(k) clearance in January 2026 and enables infants to remain close to caregivers during treatment, supporting bonding and family-integrated care models. The wearable device complements Natus Sensory’s existing hospital-based phototherapy solutions, providing clinicians greater flexibility to tailor treatment across hospital and home-care settings. Natus Sensory’s global presence and established hospital relationships will enable access to innovative technology for families and clinicians. (Link)
HealthMark Group acquires Purview, via its financial sponsors Aspect Investors, WSC & Company, Ridgemont Equity Partners, TA Associates Management, Saltoun Capital Partners and BaseFour, to expand digital access to medical imaging and modernize image sharing infrastructure The acquisition addresses the healthcare industry’s persistent reliance on physical discs for medical image sharing, with approximately two-thirds of radiological images still distributed this way. Purview’s cloud-based platform simplifies ingestion, analysis, and sharing of medical imaging data, providing quick and secure access to imaging records regardless of care delivery location. Trusted by numerous academic medical centers and five of the top ten children’s hospitals, Purview will integrate into HealthMark’s clinical data exchange solution to provide complete, timely access to medical imaging across regions, institutions, and care settings, accelerating care delivery and improving patient outcomes for authorized recipients. (Link)
Venture and Other News
Talkiatry raises oversubscribed $210M Series D led by Perceptive Advisors with Sofina, Andreessen Horowitz and Left Lane Capital to expand telepsychiatry services The New York City-based company will use proceeds to build technology and expand services across the mental health acuity spectrum, including lower-acuity offerings like couples therapy and future higher-acuity services such as intensive outpatient support. Talkiatry directly employs over 800 full-time psychiatrists and is in-network with more than 100 insurers covering over 170 million lives, delivering 3 million patient visits to date. The company’s Mindshare Partner Program partners with over one-third of the country’s top 20 health systems, enabling patient referrals while integrating with existing EMR systems and workflows, achieving cost reductions up to $700 per member per month. (Link)
Solace Health raises $130M Series C led by IVP with Menlo Ventures, SignalFire, Torch Capital, Inspired Capital, and RiverPark Ventures to scale patient advocacy platform at $1B valuation Founded in 2022, Solace Health will use proceeds to expand its national advocate network beyond 2,000 existing advocates, invest in platform and clinical research, and deepen payer and provider partnerships to embed advocacy earlier in patient journeys. The digital platform matches Medicare and Medicare Advantage patients with trained healthcare advocates who coordinate care, manage appointment logistics, attend appointments, reduce medical bills, organize documents, manage insurance appeals, and oversee care transitions. Serving over 20,000 patients monthly, 98% report better outcomes, with 95% paying no out-of-pocket costs for services. (Link)
Garner Health raises $118M Series D led by Kleiner Perkins with Redpoint, Maverick, Kaiser Permanente Ventures, Mercy and Plus Capital to scale AI-driven care navigation platform at $1.35B valuation The New York-based company will use proceeds to expand its proprietary doctor ranking platform, scale AI-driven navigation and appointment booking capabilities, and grow its team. Garner leverages medical data covering over 320 million patient records to identify high-performing doctors who follow latest research and avoid unnecessary procedures, showing top providers have 75% lower complication and mortality rates. The platform acts as a financial administrator layering atop existing health plans, covering out-of-pocket costs when employees see top providers. This results in employees paying 80% less while employers achieve 12% total healthcare cost reduction, serving over 2.5 million members across 700 clients. (Link)
Anterior raises $40M funding round led by FPV and Kinnevik with NEA and Sequoia Capital to scale AI platform for health insurers The round brings Anterior’s total funding to $64 million as the company expands its clinician-led AI platform that supports health plans with prior authorization, payment integrity, and risk adjustment workflows. Founded by physician and former Google product leader Dr. Abdel Mahmoud, Anterior deploys AI directly into clinical workflows with a team comprising 40% clinicians who contribute to the codebase. The company has deployed across major U.S. health plans including Geisinger Health Plan, built strategic integrations with HealthEdge, and supports organizations covering 50 million lives through its Forward Deployed Clinician model that pairs advanced technology with embedded clinical expertise. (Link)
Pfizer (NYSE: PFE) completes $7 Billion acquisition of Metsera (NASD: MTSR), adds MET-097i, MET-233i, and Expands Clinical Obesity Pipeline in Strategic Move for Cardiometabolic Therapeutics Leadership: The acquisition of Metsera brings new advanced obesity and cardiometabolic drug candidates, including injectable and oral therapies, accelerating innovation in this high-growth field. The deal enables rapid research, expanded expertise, and improved access to cutting-edge treatments, driven by milestone-based investments and integration of Metsera’s scientific strengths. (Link)
Day One Biopharmaceuticals (NASD: DAWN) to acquire Mersana Therapeutics (NASD: MRSN) in $285 Million Deal to Advance Novel ADC Emiltatug Ledadotin for Adenoid Cystic Carcinoma and expanded Oncology Portfolio: Emiltatug ledadotin (Emi-Le) targets B7-H4 in adenoid cystic carcinoma, showing promising early anti-tumour activity for patients lacking effective therapies. Day One’s acquisition plan supports rapid clinical progress, with milestones tied to regulatory and commercial outcomes, aiming to advance this innovative cancer treatment for diverse, underserved populations. (Link)
Galecto (NASD: GLTO) acquires Damora Therapeutics, With $285M Investment Led by Fairmount, Viking Global, Venrock, Wellington, RA Capital, Andreessen Horowitz, and Others to Advance Anti-mutCALR Therapies for Blood Cancers: The merger advances pioneering treatments for rare blood cancers, with lead antibody DMR-001 designed for greater potency and patient convenience. Expanded research and strategic guidance support rapid clinical progress, including novel therapies for acute myeloid leukaemia, improved trial designs, and broader access for affected patients. (Link)
Fabric acquires UCM Digital Health, adding 400 Payer and Employer Clients, to expand AI-Powered Virtual Care Nationwide: The acquisition expands Fabric’s reach, offering AI-powered virtual care for over one million new lives and enhancing efficiency for patients, payers, and providers. By integrating UCM’s clinical expertise, Fabric improves seamless care delivery, cost savings, and access, strengthening its network across health systems and employer partnerships nationwide. (Link)
Luma Health acquires Tonic Health from R1, Expanding Patient Intake and Follow-Up Solutions for Over 1,000 Health Systems and 100 Million Patients, for EHR-Integrated Care Innovation: The integration empowers healthcare organizations with advanced digital tools for automating patient intake, consent, and follow-up. By reducing manual tasks and streamlining data coordination, clinical teams benefit from improved workflow efficiency and better patient communication. Enhanced electronic health record connectivity ensures patients experience smoother journeys and greater access to personalized care. (Link)
Emergence, backed by The Pritzker Organization, acquires MedEvolve, to Transform AI-Driven Revenue Cycle Management for Healthcare Providers: MedEvolve will accelerate development of advanced automation and analytics tools to help healthcare organizations address operational inefficiencies and financial pressures. Its platform offers real-time insights for process improvement and margin recovery, supporting increased transparency, effective collections, and sustainable performance management in complex revenue cycle operations. (Link)
Get Well and RhythmX AI Combine Under SymphonyAI Group, to Form GW RhythmX and Advance Precision Care AI for 150 Health Systems and 85 Million Patients: The combined entity delivers integrated engagement and precision care using AI-driven data insights, streamlining patient support and clinical workflow for providers. Its enterprise-scale approach offers tailored recommendations, improved outcomes, and operational efficiency, with demonstrated success in enhancing care quality, readmission rates, and patient satisfaction across diverse healthcare settings. (Link)
Diversis Capital Unites Genesis Automation Healthcare, Kermit, and Meperia to Launch First End-to-End Clinical Supply Chain Platform and Highlight $1B in Global Annual Savings for 100+ Hospitals and Health Networks: The Genesis platform streamlines hospital and ambulatory center supply chains with unified digital management for inventory, charge capture, and contract pricing. Automated workflows and analytics improve data quality, reduce waste, and strengthen compliance, enabling clinicians to prioritize patient care while finance teams achieve greater transparency and control over spending. (Link)
Vituity Integrates Focus Medical Imaging, Expands Physician-Led Model Into Diagnostic and Interventional Radiology for Hospitals and Health Systems Nationwide: The partnership enhances clinical services with a physician-led approach, empowering medical professionals in decision-making and governance. Expanded diagnostic and interventional radiology offerings, combined with innovative teleradiology, improve operational efficiency and patient care. Hospitals and imaging centers gain more coordinated, effective, and sustainable service delivery across the healthcare continuum. (Link)
OneOncology and Cancer Specialists of North Florida (CSNF) Forge Partnership, via its financial sponsor TPG, to Elevate Community-Based Cancer Care and Expand Integrated Oncology Services Across North Florida: The collaboration improves oncology care for thousands of patients with access to advanced diagnostics, accelerated clinical research, and streamlined treatment delivery. Patients benefit from reduced wait times, comprehensive support, and integrated technology resources, while clinicians retain independence and expand expertise. The alliance promotes regional access to innovative therapies and superior care coordination. (Link)
Hyve acquires Health Grown Advisory Network (HGAN), Strengthening Healthcare Innovation Partnerships and Behavioural Health Tech Integration: The integration provides ongoing support and tailored connections for digital health innovators and organizations, enhancing marketing, strategy, and system navigation. Expanded advisory resources deepen collaboration, foster scalable partnerships, and enable health industry leaders to engage beyond traditional event cycles, increasing opportunities for impactful innovation and consumer health benefits. (Link)
The Lockwood Group acquires Research To Practice (RTP), via its financial sponsor Ares Management, expanding Global Oncology Education: The partnership enhances global oncology education by combining proven training formats with advanced consulting and communication expertise. Oncology professionals gain access to innovative, evidence-based resources reflecting current clinical advances. This collaboration delivers practical knowledge, supports professional growth, and helps clinicians make informed decisions to improve patient outcomes worldwide. (Link)
